nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Sinus headache—Metformin—polycystic ovary syndrome	0.0234	0.134	CcSEcCtD
Nabilone—Dronabinol—CYP1A1—polycystic ovary syndrome	0.0165	1	CrCbGaD
Nabilone—Hypothermia—Metformin—polycystic ovary syndrome	0.0136	0.078	CcSEcCtD
Nabilone—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0136	0.078	CcSEcCtD
Nabilone—Lightheadedness—Metformin—polycystic ovary syndrome	0.00683	0.0391	CcSEcCtD
Nabilone—Nasal congestion—Metformin—polycystic ovary syndrome	0.00608	0.0348	CcSEcCtD
Nabilone—Sweating increased—Metformin—polycystic ovary syndrome	0.00467	0.0267	CcSEcCtD
Nabilone—CNR1—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.00428	0.00529	CbGpPWpGaD
Nabilone—Drowsiness—Metformin—polycystic ovary syndrome	0.00427	0.0245	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00427	0.00527	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00417	0.00516	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00417	0.00516	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00415	0.00513	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00415	0.00513	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00404	0.00499	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00403	0.00498	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00392	0.00485	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00391	0.00483	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.0039	0.00482	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00387	0.00479	CbGpPWpGaD
Nabilone—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00382	0.0218	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00376	0.00464	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00371	0.00459	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00363	0.00448	CbGpPWpGaD
Nabilone—Eye disorder—Metformin—polycystic ovary syndrome	0.00358	0.0205	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00357	0.00442	CbGpPWpGaD
Nabilone—Flushing—Metformin—polycystic ovary syndrome	0.00356	0.0204	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00348	0.00431	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00348	0.00431	CbGpPWpGaD
Nabilone—Chills—Metformin—polycystic ovary syndrome	0.00344	0.0197	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00344	0.00425	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00335	0.00414	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00332	0.0041	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00327	0.00405	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00326	0.00403	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00325	0.00402	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00316	0.00391	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.00315	0.00389	CbGpPWpGaD
Nabilone—Vision blurred—Metformin—polycystic ovary syndrome	0.00315	0.018	CcSEcCtD
Nabilone—Tremor—Metformin—polycystic ovary syndrome	0.00313	0.0179	CcSEcCtD
Nabilone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0031	0.0177	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00308	0.0038	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00306	0.00379	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00304	0.00376	CbGpPWpGaD
Nabilone—Malaise—Metformin—polycystic ovary syndrome	0.00301	0.0172	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00301	0.00372	CbGpPWpGaD
Nabilone—Syncope—Metformin—polycystic ovary syndrome	0.00299	0.0171	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00297	0.00367	CbGpPWpGaD
Nabilone—Palpitations—Metformin—polycystic ovary syndrome	0.00295	0.0169	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00295	0.00364	CbGpPWpGaD
Nabilone—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00293	0.0168	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00291	0.0036	CbGpPWpGaD
Nabilone—Hypertension—Metformin—polycystic ovary syndrome	0.00288	0.0165	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00286	0.00354	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00285	0.00352	CbGpPWpGaD
Nabilone—Myalgia—Metformin—polycystic ovary syndrome	0.00284	0.0163	CcSEcCtD
Nabilone—Chest pain—Metformin—polycystic ovary syndrome	0.00284	0.0163	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00283	0.00349	CbGpPWpGaD
Nabilone—Discomfort—Metformin—polycystic ovary syndrome	0.00281	0.0161	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00276	0.00342	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00273	0.00337	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00272	0.00336	CbGpPWpGaD
Nabilone—Infection—Metformin—polycystic ovary syndrome	0.00271	0.0155	CcSEcCtD
Nabilone—Shock—Metformin—polycystic ovary syndrome	0.00268	0.0153	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00266	0.00329	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00266	0.00329	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00265	0.00327	CbGpPWpGaD
Nabilone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00263	0.0151	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0026	0.00322	CbGpPWpGaD
Nabilone—Anorexia—Metformin—polycystic ovary syndrome	0.0026	0.0149	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00255	0.00315	CbGpPWpGaD
Nabilone—Hypotension—Metformin—polycystic ovary syndrome	0.00255	0.0146	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00253	0.00312	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00251	0.0031	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00251	0.0031	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00248	0.0142	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00247	0.00305	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00245	0.00303	CbGpPWpGaD
Nabilone—Paraesthesia—Metformin—polycystic ovary syndrome	0.00245	0.014	CcSEcCtD
Nabilone—Dyspnoea—Metformin—polycystic ovary syndrome	0.00243	0.0139	CcSEcCtD
Nabilone—Somnolence—Metformin—polycystic ovary syndrome	0.00242	0.0139	CcSEcCtD
Nabilone—Dyspepsia—Metformin—polycystic ovary syndrome	0.0024	0.0137	CcSEcCtD
Nabilone—Decreased appetite—Metformin—polycystic ovary syndrome	0.00237	0.0136	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00237	0.00293	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00237	0.00292	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00236	0.00292	CbGpPWpGaD
Nabilone—Fatigue—Metformin—polycystic ovary syndrome	0.00235	0.0135	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00235	0.0029	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00233	0.00288	CbGpPWpGaD
Nabilone—Constipation—Metformin—polycystic ovary syndrome	0.00233	0.0133	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00228	0.00282	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00228	0.00282	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00228	0.00282	CbGpPWpGaD
Nabilone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00224	0.0129	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00224	0.00277	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00223	0.0128	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00222	0.00274	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00222	0.00274	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.0022	0.00272	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00217	0.00268	CbGpPWpGaD
Nabilone—Abdominal pain—Metformin—polycystic ovary syndrome	0.00215	0.0123	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00214	0.00265	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00213	0.00264	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00213	0.00263	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00209	0.00258	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00209	0.00258	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00208	0.00257	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00207	0.00256	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00203	0.00251	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00202	0.00249	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00201	0.00249	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00198	0.00245	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00197	0.00243	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00197	0.00243	CbGpPWpGaD
Nabilone—Asthenia—Metformin—polycystic ovary syndrome	0.00195	0.0112	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00194	0.00239	CbGpPWpGaD
Nabilone—Pruritus—Metformin—polycystic ovary syndrome	0.00193	0.011	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00192	0.00238	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.00192	0.00237	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00187	0.00231	CbGpPWpGaD
Nabilone—Diarrhoea—Metformin—polycystic ovary syndrome	0.00186	0.0107	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00186	0.0023	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00186	0.00229	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00184	0.00228	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00184	0.00228	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00184	0.00227	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00183	0.00226	CbGpPWpGaD
Nabilone—Dizziness—Metformin—polycystic ovary syndrome	0.0018	0.0103	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00179	0.00221	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00179	0.00221	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00179	0.00221	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00174	0.00215	CbGpPWpGaD
Nabilone—Vomiting—Metformin—polycystic ovary syndrome	0.00173	0.00992	CcSEcCtD
Nabilone—Rash—Metformin—polycystic ovary syndrome	0.00172	0.00984	CcSEcCtD
Nabilone—Dermatitis—Metformin—polycystic ovary syndrome	0.00172	0.00983	CcSEcCtD
Nabilone—Headache—Metformin—polycystic ovary syndrome	0.00171	0.00977	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00168	0.00208	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00167	0.00207	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00167	0.00206	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00162	0.00201	CbGpPWpGaD
Nabilone—Nausea—Metformin—polycystic ovary syndrome	0.00162	0.00927	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00162	0.002	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NPB—polycystic ovary syndrome	0.00161	0.00199	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.0016	0.00197	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00159	0.00197	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00159	0.00197	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00158	0.00196	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00158	0.00195	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00156	0.00193	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00154	0.00191	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00152	0.00189	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.0015	0.00185	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00147	0.00181	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00146	0.00181	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00146	0.0018	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00145	0.00179	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00145	0.00179	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00144	0.00178	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00144	0.00178	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00143	0.00177	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00143	0.00177	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00142	0.00175	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00136	0.00168	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00135	0.00166	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00135	0.00166	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00132	0.00163	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00131	0.00162	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.0013	0.0016	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00127	0.00157	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00127	0.00157	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00127	0.00156	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00126	0.00156	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00125	0.00155	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00125	0.00155	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00122	0.00151	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00122	0.00151	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00121	0.0015	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.0012	0.00148	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00119	0.00147	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00117	0.00145	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00116	0.00143	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00115	0.00142	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00114	0.00141	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00114	0.00141	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00112	0.00139	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00112	0.00139	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00111	0.00138	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00108	0.00134	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00107	0.00132	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00106	0.00131	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00106	0.00131	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00105	0.0013	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00102	0.00126	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000994	0.00123	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000988	0.00122	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000985	0.00122	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000964	0.00119	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000959	0.00119	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000958	0.00118	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000933	0.00115	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000926	0.00114	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000909	0.00112	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000901	0.00111	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FST—polycystic ovary syndrome	0.000878	0.00109	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000873	0.00108	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000867	0.00107	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000857	0.00106	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000849	0.00105	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000837	0.00104	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000827	0.00102	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000811	0.001	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000809	0.001	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000803	0.000993	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000793	0.00098	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000773	0.000955	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000766	0.000947	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000757	0.000935	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000753	0.000931	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000751	0.000929	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000746	0.000923	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000735	0.000909	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000727	0.000898	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000707	0.000874	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000697	0.000861	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FST—polycystic ovary syndrome	0.000689	0.000852	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000687	0.00085	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000685	0.000847	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00068	0.000841	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000672	0.000831	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000657	0.000812	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000657	0.000812	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000636	0.000787	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000635	0.000785	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00063	0.000779	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000624	0.000772	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000622	0.000769	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000615	0.00076	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000608	0.000752	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000601	0.000743	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000591	0.00073	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000586	0.000724	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000577	0.000713	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000566	0.000699	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000566	0.000699	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000547	0.000676	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000545	0.000674	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00054	0.000667	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000539	0.000667	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000526	0.000651	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000524	0.000648	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000516	0.000637	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000498	0.000616	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000495	0.000612	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000494	0.00061	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00049	0.000606	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000482	0.000596	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000477	0.00059	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000476	0.000588	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000468	0.000579	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000444	0.000549	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000444	0.000549	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000434	0.000537	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000428	0.000529	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000423	0.000524	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000414	0.000511	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000413	0.000511	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000411	0.000508	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000406	0.000502	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000391	0.000483	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000388	0.00048	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000387	0.000479	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000373	0.000461	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000367	0.000454	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000348	0.00043	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000341	0.000421	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LEP—polycystic ovary syndrome	0.00034	0.000421	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000325	0.000401	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000319	0.000394	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000304	0.000375	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000292	0.000361	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—INS—polycystic ovary syndrome	0.000291	0.000359	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000281	0.000348	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000281	0.000347	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000273	0.000337	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000267	0.00033	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000267	0.00033	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000238	0.000295	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000229	0.000284	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—INS—polycystic ovary syndrome	0.000228	0.000282	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000221	0.000273	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.00022	0.000273	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000215	0.000266	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.00021	0.000259	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000184	0.000227	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000169	0.000209	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000144	0.000178	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—polycystic ovary syndrome	0.000127	0.000157	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—polycystic ovary syndrome	9.97e-05	0.000123	CbGpPWpGaD
